Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Mechanistic Insights into Pathological Changes in the Diabetic Retina: Implications for Targeting Diabetic Retinopathy.

Roy S, Kern TS, Song B, Stuebe C.

Am J Pathol. 2017 Jan;187(1):9-19. doi: 10.1016/j.ajpath.2016.08.022. Review.

PMID:
27846381
2.

Lymphoblastoid Cell Lines as a Tool to Study Inter-Individual Differences in the Response to Glucose.

Grassi MA, Rao VR, Chen S, Cao D, Gao X, Cleary PA, Huang RS, Paterson AD, Natarajan R, Rehman J, Kern TS; DCCT/EDIC Research Group..

PLoS One. 2016 Aug 10;11(8):e0160504. doi: 10.1371/journal.pone.0160504.

3.

Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.

Lee R, Wong TY, Sabanayagam C.

Eye Vis (Lond). 2015 Sep 30;2:17. doi: 10.1186/s40662-015-0026-2. Review.

4.

Diabetic Retinopathy and Diabetic Macular Edema.

Cohen SR, Gardner TW.

Dev Ophthalmol. 2016;55:137-46. doi: 10.1159/000438970. Review.

5.

Photoreceptors in diabetic retinopathy.

Kern TS, Berkowitz BA.

J Diabetes Investig. 2015 Jul;6(4):371-80. doi: 10.1111/jdi.12312. Review.

6.

Endothelial dysfunction as a predictor of cardiovascular disease in type 1 diabetes.

Bertoluci MC, Cé GV, da Silva AM, Wainstein MV, Boff W, Puñales M.

World J Diabetes. 2015 Jun 10;6(5):679-92. doi: 10.4239/wjd.v6.i5.679. Review.

7.

Non-traditional systemic treatments for diabetic retinopathy: an evidence-based review.

Simó R, Ballarini S, Cunha-Vaz J, Ji L, Haller H, Zimmet P, Wong TY.

Curr Med Chem. 2015;22(21):2580-9. Review.

8.

Oxidative stress: implications for the development of diabetic retinopathy and antioxidant therapeutic perspectives.

Wu Y, Tang L, Chen B.

Oxid Med Cell Longev. 2014;2014:752387. doi: 10.1155/2014/752387. Review.

9.

Characterization of an environmental DNA-derived gene cluster that encodes the bisindolylmaleimide methylarcyriarubin.

Chang FY, Brady SF.

Chembiochem. 2014 Apr 14;15(6):815-21. doi: 10.1002/cbic.201300756.

10.

Diabetic macular edema: New promising therapies.

Shamsi HN, Masaud JS, Ghazi NG.

World J Diabetes. 2013 Dec 15;4(6):324-38. doi: 10.4239/wjd.v4.i6.324. Review.

11.

Systemic medical management of diabetic retinopathy.

Lingam G, Wong TY.

Middle East Afr J Ophthalmol. 2013 Oct-Dec;20(4):301-8. doi: 10.4103/0974-9233.120010. Review.

12.

Evolving strategies in the management of diabetic retinopathy.

Abu El-Asrar AM.

Middle East Afr J Ophthalmol. 2013 Oct-Dec;20(4):273-82. doi: 10.4103/0974-9233.119993. Review.

13.

The management of diabetic macular oedema.

Ross AH, Clare Bailey C.

Saudi J Ophthalmol. 2011 Apr;25(2):123-9. doi: 10.1016/j.sjopt.2011.01.011.

14.

Advances in the treatment of diabetic retinopathy.

Abu El-Asrar AM, Al-Mezaine HS.

Saudi J Ophthalmol. 2011 Apr;25(2):113-22. doi: 10.1016/j.sjopt.2011.01.005.

15.

Diabetic retinopathy - An update.

Alghadyan AA.

Saudi J Ophthalmol. 2011 Apr;25(2):99-111. doi: 10.1016/j.sjopt.2011.01.009.

16.

Diabetes-induced impairment in visual function in mice: contributions of p38 MAPK, rage, leukocytes, and aldose reductase.

Lee CA, Li G, Patel MD, Petrash JM, Benetz BA, Veenstra A, Amengual J, von Lintig J, Burant CJ, Tang J, Kern TS.

Invest Ophthalmol Vis Sci. 2014 May 2;55(5):2904-10. doi: 10.1167/iovs.13-11659.

17.
18.
19.

Novel drugs and their targets in the potential treatment of diabetic retinopathy.

Nawaz MI, Abouammoh M, Khan HA, Alhomida AS, Alfaran MF, Ola MS.

Med Sci Monit. 2013 Apr 26;19:300-8. doi: 10.12659/MSM.883895. Review.

20.

Diabetic retinopathy and VEGF.

Gupta N, Mansoor S, Sharma A, Sapkal A, Sheth J, Falatoonzadeh P, Kuppermann B, Kenney M.

Open Ophthalmol J. 2013;7:4-10. doi: 10.2174/1874364101307010004.

Items per page

Supplemental Content

Support Center